- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Understanding the market dynamics of biosimilars ; 13 (2016) 1, S. 33-46
Journal of business chemistry ; 13 (2016) 1, S. 33-46
- Creator
-
Daubenfeld, Thorsten
Dassow, Jonas
Keßler, Maximilian
Schulze, Jonas
- URN
-
urn:nbn:de:hbz:6-96289377781
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Daubenfeld, Thorsten
- Dassow, Jonas
- Keßler, Maximilian
- Schulze, Jonas
Other Objects (12)
Life science in the capital market : biosimilars
Biosimilars – Biosimilars: ja, aber
Biosimilars
Biomedical and Market Issues Surrounding the Advent of Biosimilars
Biosimilars : Handbuch
Biosimilars : ein Handbuch
Biosimilars – Alternative wirkt
Biosimilars im Fokus : Diskussionspapier zur Substitution von Biosimilars in Apotheken
European Stakeholder Learnings Regarding Biosimilars: Part I—Improving Biosimilar Understanding and Adoption
Current perspectives on biosimilars
Pharmacovigilance Considerations for Biosimilars in the USA
Interchangeability of Biosimilars: Overcoming the Final Hurdles
Life science in the capital market : biosimilars
Biosimilars – Biosimilars: ja, aber
Biosimilars
Biomedical and Market Issues Surrounding the Advent of Biosimilars
Biosimilars : Handbuch
Biosimilars : ein Handbuch
Biosimilars – Alternative wirkt
Biosimilars im Fokus : Diskussionspapier zur Substitution von Biosimilars in Apotheken
European Stakeholder Learnings Regarding Biosimilars: Part I—Improving Biosimilar Understanding and Adoption
Current perspectives on biosimilars
Pharmacovigilance Considerations for Biosimilars in the USA
Interchangeability of Biosimilars: Overcoming the Final Hurdles
Life science in the capital market : biosimilars
Biosimilars – Biosimilars: ja, aber
Biosimilars
Biomedical and Market Issues Surrounding the Advent of Biosimilars
Biosimilars : Handbuch
Biosimilars : ein Handbuch
Biosimilars – Alternative wirkt
Biosimilars im Fokus : Diskussionspapier zur Substitution von Biosimilars in Apotheken
European Stakeholder Learnings Regarding Biosimilars: Part I—Improving Biosimilar Understanding and Adoption
Current perspectives on biosimilars
Pharmacovigilance Considerations for Biosimilars in the USA